Geron Corporation

Medivation Technologies, Inc.

Jeffrey Lindquist

Sergei M Gryaznov

Ronald A Pruzan

Sebastian Bernales

Daria Zielinska

Mausumee Guha

Son Minh Pham

Roopa Rai

Brahmam Pujala

Bharat Uttam Shinde

Bhawana Bhatt

Ramniwas Jangir

Rambabu Guguloth

Satyanarayana Kallem

Vikas Ramdas Bhagwat

This disclosure provides compounds and methods of using those compounds to treat metabolic disorders and hyperproliferative disorders, including administration of the compounds in conjunction with hormone receptor antagonists.

Heterocyclic compounds and methods of use

This disclosure provides compounds and methods of using those compounds to treat liver fibrosis, including liver fibrosis which is a precursor to, is concurrent with, is associated with, or is secondary to nonalcoholic steatohepatitis (NASH); elevated cholesterol levels, and insulin resistance.

Provided herein are antisense oligonucleotides that can effectively prevent or decrease c-myc protein expression as well as decrease overall rates of cell proliferation in in vitro and mammalian in vivo models of cell proliferative disorders as well as methods for using the same.

C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders

Growing community of inventors

Redwood City, CA, United States of America

Jeffrey Lindquist